Molly Harper - 27 Nov 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Issuer symbol
CPRX
Transactions as of
27 Nov 2024
Net transactions value
-$283,850
Form type
4
Filing time
29 Nov 2024, 20:09:03 UTC
Previous filing
25 Nov 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $101,150 +17,500 $5.78 17,500 27 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $385,000 -17,500 -100% $22.00 0 27 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -17,500 -12% $0.000000 134,020 27 Nov 2024 Common Stock 17,500 $5.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
F2 Options vested in three annual tranches beginning on June 29, 2022.